We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
(+4.6%)
Cap. Flow
-$221M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$114M |
| 2 |
AET
Aetna Inc
AET
|
+$96.3M |
| 3 |
Travelers Companies
TRV
|
+$94.5M |
| 4 |
CHK
Chesapeake Energy Corporation
CHK
|
+$89M |
| 5 |
Ameren
AEE
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$247M |
| 2 |
Verizon
VZ
|
+$186M |
| 3 |
Medtronic
MDT
|
+$150M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$126M |
| 5 |
Johnson Controls International
JCI
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.44% |
| 2 | Technology | 14.68% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 11.1% |
| 5 | Energy | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Graham Holdings Company
GHC
$4.94B
| $18.1M | 0.08% |
41,713
-10,140
| -20% | -$4.22M |
|
277
iShares MSCI Japan ETF
EWJ
$23.3B
| $18.1M | 0.08% |
375,753
+15,750
| +4% | +$720K |
|
|
TLM
278
DELISTED
TALISMAN ENERGY INC
TLM
| $18.1M | 0.08% |
1,706,380
+1,472,621
| +630% | +$15.4M |
|
279
Elevance Health
ELV
$91B
| $17.8M | 0.07% |
165,542
-3,173
| -2% | -$327K |
|
280
Adobe
ADBE
$104B
| $17.7M | 0.07% |
244,931
-108,013
| -31% | -$6.97M |
|
|
MR
281
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $17.7M | 0.07% |
562,647
+8,640
| +2% | +$274K |
|
|
PRE
282
DELISTED
PARTNERRE LTD
PRE
| $17.7M | 0.07% |
161,870
-198,700
| -55% | -$21M |
|
|
BBBY
283
DELISTED
Bed Bath & Beyond Inc
BBBY
| $17.7M | 0.07% |
307,864
-158,831
| -34% | -$9.91M |
|
284
TC Energy
TRP
$63.4B
| $17.6M | 0.07% |
367,851
+73,286
| +25% | +$3.42M |
|
285
Whirlpool
WHR
$2.16B
| $17.5M | 0.07% |
125,900
+4,400
| +4% | +$646K |
|
286
Prologis
PLD
$129B
| $17.5M | 0.07% |
426,068
+190,300
| +81% | +$7.82M |
|
|
NFX
287
DELISTED
Newfield Exploration
NFX
| $17.4M | 0.07% |
392,815
+390,700
| +18,473% | +$14M |
|
|
NBIS
288
Nebius Group N.V.
NBIS
$56.9B
| $17.3M | 0.07% |
485,652
+143,117
| +42% | +$4.39M |
|
289
Humana
HUM
$47.6B
| $17.3M | 0.07% |
135,100
-36,900
| -21% | -$4.37M |
|
|
K
290
DELISTED
Kellanova
K
| $17M | 0.07% |
275,529
-959,026
| -78% | -$60.1M |
|
291
BlackRock TCP Capital
TCPC
$337M
| $17M | 0.07% |
932,193
+85,078
| +10% | +$1.43M |
|
292
Intuit
INTU
$89.4B
| $16.8M | 0.07% |
209,041
+116,464
| +126% | +$8.99M |
|
293
Pan American Silver
PAAS
$20B
| $16.8M | 0.07% |
1,095,911
-3,800
| -0.3% | -$50.4K |
|
294
iShares S&P 500 Value ETF
IVE
$49.5B
| $16.7M | 0.07% |
185,091
+44,100
| +31% | +$3.9M |
|
295
Kohl's
KSS
$1.85B
| $16.5M | 0.07% |
313,680
-47,200
| -13% | -$2.56M |
|
296
Wheaton Precious Metals
WPM
$67.9B
| $16.5M | 0.07% |
625,927
-279
| -0% | -$6.25K |
|
297
HCA Healthcare
HCA
$91.8B
| $16.3M | 0.07% |
289,276
+71,761
| +33% | +$3.79M |
|
298
iShares Morningstar US Equity ETF
ILCB
$1.28B
| $16.2M | 0.07% |
570,096
+20,800
| +4% | +$580K |
|
|
DTV
299
DELISTED
DIRECTV COM STK (DE)
DTV
| $16.2M | 0.07% |
190,142
-552,959
| -74% | -$45.1M |
|
|
SPLS
300
DELISTED
Staples Inc
SPLS
| $16.1M | 0.07% |
1,488,498
+460,407
| +45% | +$5.46M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2014 Portfolio in Review
As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
- Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
- Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
- Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
- Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
- Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
- Axa opened 103 new positions and closed 115 in Q2 2014.
- Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.
Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.